Skip to main content
Equibles

BROWN BROTHERS HARRIMAN & CO

Position in PCVX — Vaxcyte, Inc.

CIK 14661 NEW YORK, NY
Back to PCVX Full portfolio

Position in PCVX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,210,858
+$761 QoQ
Shares Held
38,033
0.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#133
of 331 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BROWN BROTHERS HARRIMAN & CO holds $12,921,641 across 41 Biotechnology names. PCVX ranks #3 (17.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,785 $4,363,773
2 RVMD
Revolution Medicines, Inc.
 15,000 $2,809,200
3 PCVX
Vaxcyte, Inc.
This page 		38,033 $2,210,858
4 INCY
Incyte Corp
 8,005 $907,446
5 REGN
Regeneron Pharmaceuticals, Inc.
 1,115 $695,247
6 MRNA
Moderna, Inc.
 8,626 $604,078
7 TECH
BIO-TECHNE Corp
 4,971 $351,201
8 TTRX
Turn Therapeutics Inc.
 23,688 $172,922

All Filings in PCVX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,210,858 38,033
2026-03-31 $2,210,097 38,033
2025-12-31 $1,754,842 38,033
2025-09-30 $1,369,948 38,033
2025-06-30 $1,236,452 38,033
2025-03-31 $1,436,126 38,033
2024-12-31 $3,113,381 38,033
2024-09-30 $4,346,030 38,033
2024-06-30 $2,871,871 38,033
2024-03-31 $2,598,034 38,033
2023-12-31 $2,388,472 38,033
2023-09-30 $1,938,922 38,033
2023-06-30 $1,899,368 38,033
2023-03-31 $1,425,476 38,033
2022-12-31 $1,823,682 38,033
2022-09-30 $912,792 38,033
2022-06-30 $827,598 38,033
2022-03-31 $918,496 38,033
2021-12-31 $904,805 38,033
2021-09-30 $964,897 38,033
2021-06-30 $856,122 38,033
2021-03-31 $751,151 38,033